Filing Details
- Accession Number:
- 0001181431-11-047356
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-29 19:12:32
- Reporting Period:
- 2011-08-25
- Filing Date:
- 2011-08-29
- Accepted Time:
- 2011-08-29 19:12:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1398276 | Thomas Farrington | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Senior Vp And Cio | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-08-25 | 2,515 | $90.94 | 4,418 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-08-25 | 775 | $90.94 | 3,643 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2011-08-25 | 1,582 | $90.94 | 5,225 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-08-25 | 488 | $90.94 | 4,737 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2011-08-25 | 1,658 | $35.85 | 6,395 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-08-25 | 1,733 | $30.06 | 8,128 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-08-25 | 2,191 | $91.04 | 5,937 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-08-25 | 1,000 | $92.17 | 4,937 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-08-25 | 200 | $93.38 | 4,737 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-08-26 | 1,000 | $88.86 | 3,737 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-08-26 | 1,694 | $90.25 | 2,043 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-08-26 | 140 | $91.24 | 1,903 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2011-08-25 | 2,515 | $0.00 | 2,515 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2011-08-25 | 1,582 | $0.00 | 1,582 | $0.00 |
| Common Stock | Employee Stock Option Right to Buy | Disposition | 2011-08-25 | 1,658 | $0.00 | 1,658 | $35.85 |
| Common Stock | Employee Stock Option Right to Buy | Disposition | 2011-08-25 | 1,733 | $0.00 | 1,733 | $30.06 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-08-25 | 2011-08-25 | No | 4 | M | Direct |
| 0 | 2011-08-25 | 2011-08-25 | No | 4 | M | Direct |
| 0 | 2011-08-25 | 2018-08-25 | No | 4 | M | Direct |
| 0 | 2011-08-25 | 2019-08-25 | No | 4 | M | Direct |
Footnotes
- Vesting of Performance-based Restricted Stock Units granted on August 25, 2008.
- Vesting of Restricted Stock Units granted on August 25, 2008.
- This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on March 4, 2011. This 10b5-1 sales plan will expire on the close of business February 16, 2012.
- The price in column 4 is a weighted average. The prices actually received ranged from $88.58 to $89.58. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $89.58 to $90.77. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $88.49 to $88.37. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $88.80 to $90.58. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
